Debora Degl’Innocenti

Author

Fondazione IRCCS Istituto Nazionale dei Tumori

Also Known As

Debora Degl'Innocenti, Debora Degl’Innocenti, Debora Degl’innocenti

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

Fondazione IRCCS Istituto Nazionale dei Tumori Helsinki University Hospital University of Helsinki

About

Debora Degl’Innocenti is an author at Fondazione IRCCS Istituto Nazionale dei Tumori specializing in medicine, cell biology, and tumor microenvironment.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	186
2	Cell Biology	3	3	128
3	Natural Sciences	1	1	45
4	Cellular Physiology	1	1	27
5	Immunology	1	1	13

Debora Degl’Innocenti

Publications

967

Citations

H-Index

Page 1

	Year	Citations
Induction of a proinflammatory program in normal human thyrocytes by the <i>RET/PTC1</i> oncogene Maria Grazia Borrello, Luisella Alberti, Andrew H. Fischer, Proceedings of the National Academy of Sciences	2005	327
The tight relationship between papillary thyroid cancer, autoimmunity and inflammation: clinical and molecular studies Marina Muzza, Debora Degl’Innocenti, Carla Colombo, Clinical Endocrinology	2010	168
miR-199a-3p displays tumor suppressor functions in papillary thyroid carcinoma Emanuela Minna, Paola Romeo, Loris De Cecco, Oncotarget	2014	102
Biological Effects of the Dual Phenotypic Janus Mutation of ret Cosegregating with Both Multiple Endocrine Neoplasia Type 2 and Hirschsprung’s Disease Elena Arighi, Anna Popsueva, Debora Degl’Innocenti, Molecular Endocrinology Cause Sporadic ThyroidBiological EffectsSomatic VariantGenetic DisorderReceptor Tyrosine Kinase	2004	72
RET/PTC1-Driven Neoplastic Transformation and Proinvasive Phenotype of Human Thyrocytes Involve Met Induction and β-Catenin Nuclear Translocation Giuliana Cassinelli, Enrica Favini, Debora Degl’Innocenti, Neoplasia	2009	58
DUSP6/MKP3 is overexpressed in papillary and poorly differentiated thyroid carcinoma and contributes to neoplastic properties of thyroid cancer cells Debora Degl’Innocenti, Paola Romeo, Eva Tarantino, Endocrine Related Cancer	2012	50
Differential interaction of Enigma protein with the two RET isoforms Maria Grazia Borrello, Elena Mercalli, Carla Perego, Biochemical and Biophysical Research Communications Protein SecretionProtein FunctionProtein AssemblyProtein FoldingNatural Sciences	2002	45
A phase II study on the role of gemcitabine plus romidepsin (GEMRO regimen) in the treatment of relapsed/refractory peripheral T-cell lymphoma patients Cinzia Pellegrini, Anna Dodero, Annalisa Chiappella, Journal of Hematology & Oncology	2016	41
Integrated Ligand-Receptor Bioinformatic and In Vitro Functional Analysis Identifies Active TGFA/EGFR Signaling Loop in Papillary Thyroid Carcinomas Debora Degl’Innocenti, Chiara Alberti, Giancarlo Castellano, PLoS ONE	2010	35
Functional characterization of the MTC-associated germline RET-K666E mutation: evidence of oncogenic potential enhanced by the G691S polymorphism Maria Grazia Borrello, Antonella Aiello, Bernard Peissel, Endocrine Related Cancer G691s PolymorphismSomatic VariantCausative Mtc MutationGenetic DisorderMedicine	2011	29

Page 1